Searched for
MAYNE PHARMA GROUP LIMITED
Swara Baby files DRHP with Sebi for Rs 1,000 crore IPOSwara Baby has filed its DRHP with Sebi for a Rs 1,000 crore IPO, comprising a Rs 500 crore fresh issue and Rs 500 crore OFS. The hygiene p...- Saleem Ahmad takes additional charge as Ircon chairman and managing directorSaleem Ahmad, CMD of Rail Vikas Nigam Limited, has taken on the additional role of leading Ircon International Limited. Ahmad stressed stak...
- Adar Poonawalla Family Office invests Rs 700 crore in Inox CleanAdar Poonawalla's family office has injected Rs 700 crore into Inox Clean Energy, This significant investment bolsters Inox Clean's integra...
- Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...
- Tata Group-owned IHCL to invest Rs 6,000-7,500 crore in capex over five years: ChandrasekaranIndian Hotels Company Limited (IHCL) is set to invest between Rs 6,000 crore and Rs 7,500 crore in capital expenditure over the next five y...
- Two Trades for Today: An auto sector major for a 6.25% upmove, a mid-cap pharma stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Disney pumps Rs 123 crore into JioStar India in fresh FDIWalt Disney's Star Group injected Rs 123 crore into JioStar India via FDI, bolstering the Reliance-Disney joint venture. This follows subst...
- Why Trump's tariffs had plenty of bark, but limited biteDonald Trump's tariffs, once feared to cripple markets, have had a surprisingly muted impact, with actual levies lower than headline rates....
- Tamil Nadu based Stalwart People Services files DRHP for Rs 150 crore IPOTamil Nadu-based Stalwart People Services has filed its DRHP with Sebi to raise Rs 150 crore through a fresh issue of shares, alongside an ...
- PRISM’s IPO filing mentions Zostel case, CCI investigationIn its UDRHP-I filing to Sebi, the company any 'adverse' outcome in legal proceedings involving Zostel may materially and adversely affect ...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- 5 silent reasons banks slash your credit card limit without warning
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27%At this point, it would be good to keep some powder dry and focus on the fundamentals of sectors, especially those where underlying changes...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
Load More
